Balance Sheet
Cash Flow Statement
AmortizationAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in ReceivablesChange in TaxesChange in Working CapitalDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Cemex Sab De Cv (CXMSF) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Cemex Sab De Cv (CXMSF) over the last 14 years, with Q4 2025 value amounting to -$301.0 million.

  • Cemex Sab De Cv's Gains from Investment Securities fell 26265.06% to -$301.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$301.0 million, marking a year-over-year increase of 6571.75%. This contributed to the annual value of -$301.0 million for FY2025, which is 6475.41% up from last year.
  • According to the latest figures from Q4 2025, Cemex Sab De Cv's Gains from Investment Securities is -$301.0 million, which was down 26265.06% from -$87.0 million recorded in Q3 2025.
  • In the past 5 years, Cemex Sab De Cv's Gains from Investment Securities ranged from a high of -$46.0 million in Q1 2021 and a low of -$362.0 million during Q3 2024
  • Its 3-year average for Gains from Investment Securities is -$160.9 million, with a median of -$87.0 million in 2025.
  • Over the last 5 years, Cemex Sab De Cv's Gains from Investment Securities had its largest YoY gain of 7596.69% in 2025, and its largest YoY loss of 26265.06% in 2025.
  • Cemex Sab De Cv's Gains from Investment Securities (Quarter) stood at -$46.0 million in 2021, then plummeted by 80.43% to -$83.0 million in 2024, then plummeted by 262.65% to -$301.0 million in 2025.
  • Its Gains from Investment Securities stands at -$301.0 million for Q4 2025, versus -$87.0 million for Q3 2025 and -$77.0 million for Q2 2025.